UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial

Annals of oncology, 2017-01, Vol.28 (1), p.128-135

2017

Volltextzugriff (PDF)

Quantitative Measurement of BIM Protein in Lung Cancer

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S11-S11

2014

Volltextzugriff (PDF)

Immunological differences between primary and metastatic breast cancer

Annals of oncology, 2018-11, Vol.29 (11), p.2232-2239

2018

Volltextzugriff (PDF)

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

Annals of oncology, 2015-02, Vol.26 (2), p.259-271

2015

Volltextzugriff (PDF)

β-Catenin Functions Mainly as an Adhesion Molecule in Patients with Squamous Cell Cancer of the Head and Neck

Clinical cancer research, 2005-04, Vol.11 (7), p.2471-2477

2005

Volltextzugriff (PDF)

B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma

Annals of oncology, 2024-04, Vol.35 (4), p.340-350

2024

Volltextzugriff (PDF)

P2.12-01 Intratumoral Conventional Type 1 Dendritic Cells (cDC1s) Predict Response to Immunotherapy in Human Non-small Cell Lung Cancer cancer (NSCLC)

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S150

2022

Volltextzugriff (PDF)

Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation

Oncogene, 2014-03, Vol.33 (11), p.1438-1447

2014

Volltextzugriff (PDF)

Corrigendum to “Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma” [Oral Oncol. 86 (2018) 278–287]

Oral oncology, 2019-06, Vol.93, p.129-129

2019

Volltextzugriff (PDF)

HSP90 as a marker of progression in melanoma

Annals of oncology, 2008-03, Vol.19 (3), p.590-594

2008

Volltextzugriff (PDF)

Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer

Annals of oncology, 2010-03, Vol.21 (3), p.466-473

2010

Volltextzugriff (PDF)

Corrections to “Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial”

Annals of oncology, 2019-06, Vol.30 (6), p.1018-1018

2019

Volltextzugriff (PDF)

correction to: Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial

Annals of oncology, 2018-10, Vol.29 (10), p.2152-2152

2018

Volltextzugriff (PDF)

Quantitative Measurement of BIM Protein in Lung Cancer: Diagnosis/Staging

International journal of radiation oncology, biology, physics, 2014-11, Vol.90 (5), p.S11-S11

2014

Volltextzugriff (PDF)

1006 The anti-IGF-IR antibody figitumumab (CP-751,871) is active in patients with lung adenocarcinoma undergoing epithelial-tomesenchymal transition

European journal of cancer supplements, 2009, Vol.7 (2), p.88-89

2009

Volltextzugriff (PDF)

Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancer

Annals of oncology, 2012-08, Vol.23 (8), p.2059-2064

2012

Volltextzugriff (PDF)

Molecular Cloning of Human E-Cadherin Suggests a Novel Subdivision of the Cadherin Superfamily

Biochemical and biophysical research communications, 1994-05, Vol.200 (3), p.1754-1761

1994

Volltextzugriff (PDF)

Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/ neu Amplification: Evaluation According to ASCO/CAP Criteria : Brunelli M, Manfrin E, Martignoni G, et al (Univ of Verona, Italy; et al) Am J Clin Pathol 131:678-682, 2009

Breast diseases, 2009, Vol.20 (4), p.376-377

2009

Volltextzugriff (PDF)

Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neu Amplification: Evaluation According to ASCO/CAP Criteria

Breast diseases, 2009-01, Vol.20 (4), p.376-377

2009

Volltextzugriff (PDF)

Automated quantitative analysis of DCC tumor suppressor protein in ovarian cancer tissue microarray shows association with β-catenin levels and outcome in patients with epithelial ovarian cancer

Annals of oncology, 2006-12, Vol.17 (12), p.1797-1802

2006

Volltextzugriff (PDF)

Correlations between BRCA status, molecular markers and clinical variables in early onset conservatively managed breast cancer

International journal of radiation oncology, biology, physics, 2001-11, Vol.51 (3), p.193-193

2001

Volltextzugriff (PDF)

Molecular Cloning Reveals Alternative Splice Forms of Human α(E)-Catenin

Biochemical and biophysical research communications, 1994-09, Vol.203 (3), p.1691-1699

1994

Volltextzugriff (PDF)

419 Automated quantitative in-situ method of protein analysis (AQUA) demonstrates that components of the retinoblastoma (Rb) pathway are potential molecular targets in oropharyngeal squamous cell cancer

European journal of cancer supplements, 2004-09, Vol.2 (8), p.125-126

2004

Volltextzugriff (PDF)

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up

Annals of oncology, 2017-01, Vol.28 (1), p.75-82

2017

Volltextzugriff (PDF)

Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function

Annals of oncology, 2017-01, Vol.28 (1), p.83-89

2017

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial

Quantitative Measurement of BIM Protein in Lung Cancer

Immunological differences between primary and metastatic breast cancer

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

β-Catenin Functions Mainly as an Adhesion Molecule in Patients with Squamous Cell Cancer of the Head and Neck

B-cell infiltration is associated with survival outcomes following programmed cell death protein 1 inhibition in head and neck squamous cell carcinoma

P2.12-01 Intratumoral Conventional Type 1 Dendritic Cells (cDC1s) Predict Response to Immunotherapy in Human Non-small Cell Lung Cancer cancer (NSCLC)

Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation

Corrigendum to “Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma” [Oral Oncol. 86 (2018) 278–287]

HSP90 as a marker of progression in melanoma

Growth factor receptor-bound protein-7 (Grb7) as a prognostic marker and therapeutic target in breast cancer

Corrections to “Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial”

correction to: Pathway level alterations rather than mutations in single genes predict response to HER2-targeted therapies in the neo-ALTTO trial

Quantitative Measurement of BIM Protein in Lung Cancer: Diagnosis/Staging

1006 The anti-IGF-IR antibody figitumumab (CP-751,871) is active in patients with lung adenocarcinoma undergoing epithelial-tomesenchymal transition

Association between the nuclear to cytoplasmic ratio of p27 and the efficacy of adjuvant polychemotherapy in early breast cancer

Molecular Cloning of Human E-Cadherin Suggests a Novel Subdivision of the Cadherin Superfamily

Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/ neu Amplification: Evaluation According to ASCO/CAP Criteria : Brunelli M, Manfrin E, Martignoni G, et al (Univ of Verona, Italy; et al) Am J Clin Pathol 131:678-682, 2009

Genotypic Intratumoral Heterogeneity in Breast Carcinoma With HER2/neu Amplification: Evaluation According to ASCO/CAP Criteria

Automated quantitative analysis of DCC tumor suppressor protein in ovarian cancer tissue microarray shows association with β-catenin levels and outcome in patients with epithelial ovarian cancer

Correlations between BRCA status, molecular markers and clinical variables in early onset conservatively managed breast cancer

Molecular Cloning Reveals Alternative Splice Forms of Human α(E)-Catenin

419 Automated quantitative in-situ method of protein analysis (AQUA) demonstrates that components of the retinoblastoma (Rb) pathway are potential molecular targets in oropharyngeal squamous cell cancer

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up

Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function

Suchergebnisse filtern